International
E.U. Reg. Backs Lung Cancer Drug
EUROPE – Astrazeneca said on Friday its cancer drug Enhertu was recommended by the European Medicine Agency’s human medicines committee as a monotherapy to treat patients with a type of non-small cell lung cancer.
-
International19 hours agoBTVI Named UNESCO Centre of Vocational Excellence
-
National2 days agoFirst Time Voters Weigh in on Election Hopes
-
National11 hours agoEaster Monday Sees Surge in Voter Registration
-
Sports2 days agoJavelin Throwers Win First Medals for Team Bahamas
-
Lifestyle2 days agoHarmonizers Represent All Generations
-
National1 day agoFamily Island Airports: A Promised Improvement From Last Election
-
Sports1 day agoLong Jump Medals Lead Strong Morning Session for Team Bahamas
-
Lifestyle1 day agoDesigners Behind Third Freeport Fashion Week



